View full meeting coverage »

Eyetube Meeting Coverage:

2017 American Society of Retina Specialists Annual Meeting

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Revisiting VISTA: Nonperfusion and Aflibercept

  Channels: Retina | Posted 8/13/2017

Charles Wykoff, MD, PhD, reviews an analysis of data from the VISTA trial to find out more about the relationship between aflibercept (Eylea, Regeneron) and retinal nonperfusion in diabetic patients.


13 / 14 Series: 2017 American Society of Retina Specialists Annual Meeting